NCT06910566Active, not recruiting
Factors Sustaining Tobacco Abstinence in Cancer Patients Treated With Radio-chemotherapy or Radiotherapy
A Prospective Study on the Factors Sustaining Tobacco Abstinence in Patients Treated With Radio-chemotherapy or Radiotherapy Alone for Head and Neck or Lung Cancer
Source: ClinicalTrials.gov · Last updated 18 Mar 2026
Brief summary (registry, in English)
The TABAC STOP ORL POUMON study aims to evaluate the factors influencing long-term smoking cessation in patients with head and neck cancer (HNC) or lung cancer undergoing radiotherapy or chemoradiotherapy. This is a single-center observational study, following patients at 1, 6, and 12 months after treatment completion. The primary objective is to determine the proportion of abstinent patients at 6 months, while secondary objectives analyze factors influencing abstinence, smoking trajectories, and reasons for relapse. A total of 100 patients will be included to ensure robust statistical analysis.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 100 (estimated)
- First submitted
- 19 Mar 2025
- Start date
- 28 Mar 2022
- Primary completion date
- Nov 2026
- Lead sponsor
- Centre Oscar Lambret
- Diseases
- Head and neck cancer, Lung cancer
- NCT number
- NCT06910566
What you commit to
- Study type: Observational
- Planned participants: 100
- From 28 Mar 2022 to the primary completion date, Nov 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patient receiving palliative treatment
Other
- Patient under guardianship or curatorship
- Study Exit Criteria :
- \- Protocol-defined exit : After the 12-month consultation
- Early exit :
- Withdrawal of consent for data collection
- Death of the patient
Who the study is looking for
- Patient aged 18 years or older
- Diagnosed with head and neck cancer or lung cancer
- Undergoing curative treatment with chemoradiotherapy, radiotherapy alone, or stereotactic radiotherapy
- Current or former smoker
- Patient covered by a social security scheme
- Patient informed and having given consent for data collection
- Patients with human papillomavirus (HPV) may also be included
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Centre Oscar Lambret Coordinator of this site? Confirm its status | Lille | France | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.